Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Clasificación en acciones #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Precio por acción
$4.84
Capitalización bursátil
$633.18M
Cambio (1 día)
3.20%
Cambio (1 año)
0.00%
País
GB
Comercio Exscientia plc (EXAI)

Categoría

Healthcare
Ganancias de Exscientia plc (EXAI)
Ganancias en Sep 2024 TTM: $-207.65M
Secondo gli ultimi rapporti finanziari di Exscientia plc, gli utili attuali della società sono $-207.65M. Nel 2022, la società ha registrato un utile di $-167.36M, una disminución en comparación con agli utili del 2021, che erano di $-56.36M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Exscientia plc desde 2019 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-207.65M 0.64%
2023 $-206.34M 23.29%
2022 $-167.36M 196.95%
2021 $-56.36M 24.08%
2020 $-45.42M 224.78%
2019 $-13.99M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -9,951.57%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -2,336.03%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -2,618.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -1,129.45%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -877.39%
AU